Manolopoulos K, Suwandinata F, Tinneberg HR Endometriose und Infertilität Journal für Reproduktionsmedizin und Endokrinologie - Journal of Reproductive Medicine and Endocrinology 2005; 2 (5): 291-295 Volltext (PDF) Summary Übersicht
| ||||||||||
Abbildung 2: Endometriose - Veränderungen Schematische Darstellung der immunologischen Veränderungen bei Endometriose (IL-1β: Interleukin-1β; PDGF: Platelet Derived Growth Factor; TGFα/-β: Transforming Growth Factor α/β; IL-6, -8: Interleukin-6, -8; VEGF: Vascular Endothelial Growth Factor; EGF: Epidermal Growth Factor; IGF’s: Insulin-like Growth Factors; PD-ECGF: Platelet-derived Endothelial Cell Growth Factor; FGF’s: Fibroblast Growth Factors; Endo1: Endophilin 1) |
![]()
Abbildung 2: Endometriose - Veränderungen
Schematische Darstellung der immunologischen Veränderungen bei Endometriose (IL-1β: Interleukin-1β; PDGF: Platelet Derived Growth Factor; TGFα/-β: Transforming Growth Factor α/β; IL-6, -8: Interleukin-6, -8; VEGF: Vascular Endothelial Growth Factor; EGF: Epidermal Growth Factor; IGF’s: Insulin-like Growth Factors; PD-ECGF: Platelet-derived Endothelial Cell Growth Factor; FGF’s: Fibroblast Growth Factors; Endo1: Endophilin 1) |